Clinical Study Highlights How Advanced Robotic Myomectomy Helps Women Safeguard Fertility and Reproductive Choices

A 10-year clinical study of 243 robotic-assisted myomectomy procedures, performed by Dr. Rooma Sinha, including 114 women seeking fertility enhancement, has demonstrated strong reproductive outcomes, with no major surgical complications or uterine rupture reported during subsequent pregnancies. The findings reflect a decade of surgical commitment focused on helping women manage complex gynaecological conditions while preserving their reproductive choices and long-term wellbeing.

The study was led by Dr Rooma Sinha, Honorary Professor and Director of Robotic Surgery at Apollo Hospital, Hyderabad, conducted in collaboration with the Department of Pathology at Apollo Hospitals, Hyderabad.

Uterine fibroids are among the most common non-cancerous tumours affecting women, particularly during their reproductive years. Studies suggest that a significant proportion of women develop fibroids by the age of 40, although many remain undiagnosed. For many women, the diagnosis often arrives during late stages shaped by career progression, family planning decisions, and personal aspirations. In some cases, fibroids can distort the uterine cavity, interfere with embryo implantation, contribute to recurrent pregnancy loss, or cause heavy menstrual bleeding and pelvic pain.

The study examined women who underwent robotic-assisted myomectomy using the da Vinci surgical system. This minimally invasive procedure removes uterine fibroids while preserving the uterus. Fibroids can affect fertility by distorting the uterine cavity or disrupting embryo implantation. The study reported a higher pregnancy rate of 86.04% and live-birth rates of 73.25% in the group of patients who underwent robotic myomectomy. Notably, this represents one of the highest pregnancy and live birth rates reported in global studies. The study also observed zero instances of uterine rupture during subsequent pregnancies, underscoring the importance of surgical precision in protecting uterine integrity for women who wish to conceive later.

Dr Rooma explains that advanced robotic technologies, such as the da Vinci system, allow surgeons to access difficult-to-reach areas in the pelvis. It enables surgeons to perform multi-layer suturing, which is not easy using laparoscopic instruments, supporting meticulous reconstruction that is critical when future pregnancies are planned.

“For most women, recovery is not just physical but also emotional. Knowing that a surgery is designed to protect their future fertility offers them reassurance at a time when they are already coping with the stress of a diagnosis. The combination of less pain, minimal scarring, and faster return to daily activities can make a significant difference in how they move forward after treatment. This is especially pronounced in women who have to find a balance in managing work and family responsibilities,” Dr. Sinha added.

Dr. Rooma Sinha further added, “Studies using the da Vinci surgical system have shown that enhanced 3D magnification and precision tools enable seamless dissection and suturing, which may help preserve ovarian reserve and uterine strength. This supports both overall gynecological health and the possibility of conceiving in the future, giving women greater confidence in planning the next chapter of their lives.”

With continued refinement of surgical techniques and greater training opportunities for gynaecologists, robotic-assisted procedures using evidence-based technologies such as da Vinci will pave the way for more patient-centric solutions in managing conditions that affect both women’s health and fertility, reinforcing a broader shift toward care models that recognise women not only as patients, but as individuals making informed decisions about their health, families, and futures.